Health Care/Hospital

QBiotics Welcomes TDM Growth Partners As Cornerstone Investor in a Capital Raise To Accelerate Drug Development Timelines

Key highlights: * QBiotics welcomes TDM Growth Partners as cornerstone investor * TDM Growth Partners is investing A$50 million into QBiotics to accelerate QBiotics' human drug development pipeline, support marketing of the company's veterinary pharmaceutical STELFONTA® and strengthen the QBi...

2021-03-16 06:35 3098

The Public Health Agency of Canada and the University of Manitoba recruiting a scientific leader to head Canada's National Microbiology Laboratory

WINNIPEG, MB, March 16, 2021 /PRNewswire/ -- The Public Health Agency of Canada and theUniversity of Manitoba are collaborating in the recruitment of a scientific leader in infectious disease laboratory science to leadCanada's National Microbiology Laboratory (NML). This individual will hold a fa...

2021-03-16 03:19 1433

CBC Group Announces the Appointment of Roger Perlmutter as Science Partner

SHANGHAI, March 15, 2021 /PRNewswire/ -- CBC Group ("CBC"), a healthcare-dedicated investment firm, is pleased to announce that Roger M. Perlmutter, M.D., Ph.D., currently non-Executive Chairman, Merck Research Laboratories, joins CBC as Science Partner and a member of its Scientific Advisory Bo...

2021-03-15 22:00 3399

Microba Life Sciences partners with Unilever to target sleep through the gut microbiome

BRISBANE, Australia, March 15, 2021 /PRNewswire/ -- Experts in gut microbiome analysis, Microba Life Sciences , is empowering global consumer goods companyUnilever  to take a novel approach to this problem by exploring the links between sleep...

2021-03-15 21:59 3373

BioVaxys Enters Major Bioproduction Agreement With Wuxi Biologics (Hong Kong) Ltd. To Synthesize Proteins For Its SARS-CoV-2 Vaccine And COVID-T™ Immunodiagnostic Programs

VANCOUVER, British Columbia, March 15, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into a major bioproduction agreement w...

2021-03-15 20:00 3623

Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-bindin...

2021-03-15 19:00 3454

Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-bindin...

2021-03-15 19:00 5428

AXA rolls out new global brand campaign to inspire confidence and progress

HONG KONG, March 15, 2021 /PRNewswire/ -- Embodying its "Know You Can" brand signature, AXA announces today the launch of its new global brand campaign, with Hong Kong being the first market in Asia to activate a series of promotion. AXA rolls out...

2021-03-15 18:20 5705

Aiforia appoints Swedbank as lead advisor to explore financing options

HELSINKI, March 15, 2021 /PRNewswire/ -- Aiforia Technologies Oy ("Aiforia" or "the Company") has appointed Swedbank AB (publ) as their lead financial advisor to explore different financing options, including possibilities for an Initial Public Offering (IPO) by listing the Company's shares on Na...

2021-03-15 16:00 1943

Prixa, Generali Indonesia, and Lifepack Work Together in Bringing Better Healthcare Experience to Users

JAKARTA, Indonesia, March 15, 2021 /PRNewswire/ -- Prixa, the first Artificial Intelligence-powered healthcare platform inIndonesia, collaborated with Generali Indonesia, one of the leading insurance companies in the country, in releasing a new solution to enhance Generali's customer experience i...

2021-03-15 15:27 5113

Antengene Included in the Shenzhen-Hong Kong Stock Connect

SHANGHAI and HONG KONG, March 14, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and o...

2021-03-15 09:40 4940

Antengene Appoints Minyoung Kim as General Manager of Antengene South Korea

SHANGHAI and SEOUL, South Korea, March 15, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematolo...

2021-03-15 08:00 4133

Agiomix Receives the First ISO 15189 Accreditation for Next Generation Sequencing in the Region

DUBAI, UAE, March 15, 2021 /PRNewswire/ -- Agiomix has received the ISO 15189:2012 Accreditation from the Emirates International Accreditation Centre for Next Generation Sequencing clinical assays. Agiomix Labs, Dubai, ...

2021-03-15 07:50 2681

SuperTrans Medical appoints Australian partners to provide crucial clinical research in the battle against drug-resistant bacteria

MELBOURNE, Australia, March 15, 2021 /PRNewswire/ -- SuperTrans Medical has announced the appointment of three Australian companies to play pivotal roles in an upcoming clinical drug trial that offers new hope in the plight against antimicrobial resistance (AMR), which the World Health Organisati...

2021-03-15 07:08 1980

Thinklabs Announces Medical Device Single Audit Program (MDSAP) Certification and TGA Approval in Australia

Thinklabs is opening business to Australian territories, inclusive of hospitals, private practices, and medical facilities. CANBERRA, Australia, March 9, 2021 /PRNewswire/ -- Thinklabs, manufacturer of Thinklabs One, the smallest, most powerful electronic stethoscope in the world, today ann...

2021-03-12 23:06 4891

Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman

DUBLIN, Ohio, March 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately$1 billion, which includes buyer's assumption of certain liabilities and seller's retention o...

2021-03-12 22:00 9036

Medeze Commended by Frost & Sullivan for Dominating the Stem Cell Banking Market with Its Pioneering, Full Spectrum Services

Medeze's expansion strategies and customer-focused innovation in MSC banks and regenerative therapies have enabled it to garner a major share of the market SINGAPORE, March 12, 2021 /PRNewswire/ -- Based on its recent analysis of the Southeast Asia stem cell banking market, Frost & Sullivan recog...

2021-03-12 17:55 4337

Farrer Park Hospital Expands Sustainability Efforts with Tree Planting Session along Sengkang East Way

SINGAPORE, March 12, 2021 /PRNewswire/ -- Led by Chief Executive Officer Dr. Peng Chung Mien, some 25 representatives fromFarrer Park Hospital joined in the hospital's inaugural tree planting session in the morning ofMarch 12, 2021 at Sungei Serangoon Park Connector. ...

2021-03-12 14:00 3254

Harbour BioMed Announces Dosing of First Patient in Tanfanercept Phase III Clinical Trial

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SHANGHAI and SUZHOU, China, March 12, 2021 /PRNewswire/ -- Harbour BioMed (HBM) (HKEX: 02142) today announced the dosing of the first patient in the Phase III clinical trial of its new global investigational tumor necrosis factor (TNF) receptor-1 f...

2021-03-12 09:00 6604

Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials

- 100% protection against severe disease - Final analysis in U.K. trial confirms 96% efficacy against original strain of COVID-19 - Efficacy against variants confirmed in U.K. and South Africa GAITHERSBURG, Md., March 12, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnolog...

2021-03-12 05:04 4595
1 ... 823824825826827828829 ... 859

Week's Top Stories